Literature DB >> 10880874

Effects of moderate altitude on exhaled nitric oxide, erythrocytes lipid peroxidation and superoxide dismutase levels.

N A Güzel1, H Sayan, D Erbas.   

Abstract

The purpose of this study was to investigate the effects of staying at a moderate altitude (2,300 m, 7 d) on the levels of plasma nitrite, exhaled nitric oxide (NO), malondialdehyde (MDA) and superoxide dismutase (SOD). Measurements were obtained from 9 female (mean age 18.3 +/- 2) and 9 male (mean age 19.3 +/- 3.7) cross-country volunteer skiers: before, during (1st day, 7th day) and after staying at a moderate altitude. Exhaled nitric oxide levels were measured only before and after staying at the altitude. Nitrite levels increased throughout the stay at the altitude, while MDA levels decreased. In parallel with the nitrite levels, SOD activities were also found to have increased. Exhaled NO values were decreased after the stay at the moderate altitude. These results show that altitude hypoxia causes decreased in NO levels in the lung but increased systemic NO levels in the blood due to inhibition of erythrocyte lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880874     DOI: 10.2170/jjphysiol.50.187

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  3 in total

1.  Variability of FeNO in healthy subjects at 2240 meters above sea level.

Authors:  Laura Gochicoa-Rangel; Fermín Rojas-Cisneros; José Luis Miguel-Reyes; Selene Guerrero-Zúñiga; Uri Mora-Romero; Ana Karen Maldonado-Mortera; Luis Torre-Bouscoulet
Journal:  J Clin Monit Comput       Date:  2015-07-15       Impact factor: 2.502

Review 2.  Oxygen transport in blood at high altitude: role of the hemoglobin-oxygen affinity and impact of the phenomena related to hemoglobin allosterism and red cell function.

Authors:  Michele Samaja; Tiziano Crespi; Marco Guazzi; Kim D Vandegriff
Journal:  Eur J Appl Physiol       Date:  2003-09-18       Impact factor: 3.078

Review 3.  Lung oxidative damage by hypoxia.

Authors:  O F Araneda; M Tuesta
Journal:  Oxid Med Cell Longev       Date:  2012-08-26       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.